ASE Tech Files 13D for Ainos, Inc.

TL;DR

**ASE Tech now has a stake in Ainos, Inc. (ANNS). Watch this space.**

AI Summary

ASE Technology Holding Co., Ltd. has filed a Schedule 13D for Ainos, Inc. on May 8, 2024. The filing indicates a change in ownership or control, with ASE Technology Holding Co., Ltd. being the filer. Ainos, Inc. is a pharmaceutical preparations company incorporated in Texas.

Why It Matters

This filing signals a significant change in the ownership structure of Ainos, Inc., potentially impacting its strategic direction and market position. Investors should monitor further developments from ASE Technology Holding Co., Ltd.

Risk Assessment

Risk Level: medium — Schedule 13D filings can indicate activist investor intentions or significant stake-building, which may lead to volatility or strategic shifts for the subject company.

Key Players & Entities

• ASE Technology Holding Co., Ltd. (company) — Filer of the Schedule 13D
• Ainos, Inc. (company) — Subject company of the Schedule 13D
• 20240508 (date) — Filing date of the Schedule 13D

FAQ

Key Financial Figures

• $0.01 — ame of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti
• $9,000,000 — te in the aggregate principal amount of $9,000,000 pursuant to a Convertible Note and Warr
• $4.50 — f Common Stock at a conversion price of $4.50 per share (or 2,000,000 shares), subjec
• $2,000,000 — tted to pay a total aggregate amount of $2,000,000 to the Issuer in exchange for convertib
• $1,000,000 — (s) in three tranches in the amounts of $1,000,000 (the “First Tranche”), $500
• $500,000 — ,000 (the “First Tranche”), $500,000 (the “Second Tranche”), and
• $500,00 — (the “Second Tranche”), and $500,00 0 (the “Third Tranche”) con
• $1,500,000 — ss milestones. ASE Test Taiwan provided $1,500,000 on as April 12, 2023 and the remaining
• $7.50 — Common Stock at the conversion price of $7.50 per share (or 282,666 shares) , subject

Filing Documents

• dp210911_sc13d.htm (SC 13D) — 126KB
• dp210911_ex01.htm (EX-1) — 8KB
• 0000950103-24-006446.txt ( ) — 136KB

and Item 6

Item 3 and Item 6. (2) Based on the sum of (i) 6,144,506 shares of common stock outstanding as of March 31, 2024 as set forth in the Registration Statement on Form S-1 of the Issuer filed with the SEC on April 8, 2024, (ii) 282,666 shares of common stock convertible pursuant to the 2023 Agreement (as defined below) and (iii) 2,000,000 shares of common stock convertible pursuant to the 2024 Agreement (as defined below). CUSIP No. 00902F303 1 NAME OF REPORTING PERSON: ASE Test, Inc. (“ASE Test Taiwan”) 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS): (a) (b) 3 SEC USE ONLY: 4 SOURCE OF FUNDS (SEE INSTRUCTIONS): WC 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e): 6 CITIZENSHIP OR PLACE OF ORGANIZATION: Taiwan, Republic of China NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER: 0 8 SHARED VOTING POWER: 2,312,077 (1) 9 SOLE DISPOSITIVE POWER: 0 10 SHARED DISPOSITIVE POWER: 2,312,077 (1) 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 2,312,077 (1) 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 27.4% (2) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): CO ________________________ (1) Represents beneficial ownership of 2,312,077 shares of Common Stock, $0.01 par value (the “Common Stock”), of Ainos, Inc., a Texas corporation (the “Issuer”) consisting of the following: (i) 29,411 shares owned directly by ASE Test Taiwan (as defined below); (ii) 282,666 shares pursuant to the 2023 Agreement (as defined below) between ASE Test Taiwan and the Issuer; and (iii) 2,000,000 shares of common stock pursuant to the 2024 Agreement (as defined below) between ASE Test Taiwan and the Issuer. For further details, please see

and Item 6

Item 3 and Item 6. (2) Based on the sum of (i) 6,144,506 shares of common stock outstanding as of March 31, 2024 as set forth in the Registration Statement on Form S-1 of the Issuer filed with the SEC on April 8, 2024, (ii) 282,666 shares of common stock convertible pursuant to the 2023 Agreement (as defined below) and (iii) 2,000,000 shares of common stock convertible pursuant to the 2024 Agreement (as defined below). Item 1. Security and Issuer This Schedule 13D is being filed to reflect the acquisition by ASE Test Taiwan (as defined below) of a Convertible Note in the aggregate principal amount of $9,000,000 pursuant to a Convertible Note and Warrant Purchase Agreement entered into on May 3, 2024 (the “2024 Agreement”) between the Issuer and ASE Test Taiwan. The note bears 6% compound interest and has a three-year term. The note will be convertible into shares of Common Stock at a conversion price of $4.50 per share (or 2,000,000 shares), subject to customary anti-dilution adjustments. This statement on Schedule 13D (this “Statement”) relates to the Common Stock, par value $0.01 per share of the Issuer. The address of the principal executive corporate offices of the Issuer is 8880 Rio San Diego Drive, Suite 800, San Diego, CA 92108. Item 2. Identity and Background (a)-(c) This Schedule 13D is being filed by (i) ASE Technology Holding Co., Ltd., a Taiwanese corporation (“ASX”), with a principal executive office at 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan, Republic of China, and (ii) its indirect wholly-owned subsidiary, ASE Test, Inc., a Taiwanese corporation (“ASE Test Taiwan”), with a principal executive office at 10, West 5th Street, Nanzih Dist., Kaohsiung, 811, Taiwan (ASX and ASE Test Taiwan, collectively, the “Reporting Persons”). ASE Test Taiwan is directly wholly-owned by Advanced Semiconductor Engineering, Inc., a Taiwan company, which is itself directly held by ASX.

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: May 8, 2024 ASE TECHNOLOGY HOLDING CO., LTD. By: /s/ Joseph Tung Name: Joseph Tung Title: Director and Chief Financial Officer ASE TEST INC. By: /s/ Alan Li Name: Alan Li Title: Director Schedule A Directors and Executive Officers of ASE Technology Holding Co., Ltd. Name of director or executive officer Residence or business address Present principal occupation or employment Nationality Jason C.S. Chang 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan Republic of China Director and Chairman Singapore Richard H.P. Chang 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan Republic of China Director, Vice Chairman and President Hong Kong Chi-Wen Tsai 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan Republic of China Director; Chairman and President, Siliconware Precision Industries Co., Ltd. Taiwan Yen-Chun Chang 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan Republic of China Director; Chief Operating Officer, Siliconware Precision Industries Co., Ltd. Taiwan Tien Wu 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan Republic of China Director and Chief Operating Officer Taiwan Joseph Tung Room 1901, No. 333, Section 1 Keelung Rd. Taipei, 110, Taiwan, Republic of China Director and Chief Financial Officer Taiwan Raymond Lo 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan Republic of China Director; General Manager, ASE Test Taiwan and Kaohsiung packaging facility Taiwan Tien-Szu Chen 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan Republic of China Director; General Manager, Advanced Semiconductor Engineering Inc. Chung-Li branch Taiwan Rutherford Chang 26, Chin 3rd Rd., Nanzih Dist., Kaohsiung, 811, Taiwan Republic of China Director; Gener

View Full Filing

View this SC 13D filing on SEC EDGAR